Clinical Application Value of a Preset Marking Line in Lacrimal Endoscopic Surgery

Pan Xiao, D. Yang, Zhengru Huang, Qian Xing, Jian-Jun Tao, Yifang Meng, Jian Li, Jiong Lu
{"title":"Clinical Application Value of a Preset Marking Line in Lacrimal Endoscopic Surgery","authors":"Pan Xiao, D. Yang, Zhengru Huang, Qian Xing, Jian-Jun Tao, Yifang Meng, Jian Li, Jiong Lu","doi":"10.3760/CMA.J.ISSN.1674-845X.2020.01.011","DOIUrl":null,"url":null,"abstract":"Objective: \nTo explore the clinical application value of a preset marking line in lacrimal endoscopic surgery and evaluate its effect on surgical complications. \n \n \nMethods: \nThis was a prospective analysis of clinical data from 60 patients (60 eyes) with lacrimal duct obstruction who had lacrimal endoscopic surgery in Changshu No.2 People's Hospital from June 2015 to December 2018. All patients were divided into two groups, a control group or observation group according to the even or odd numbers assigned to hospital patients. The control group (odd numbers) had no intra-surgery preset marking line. The observation group (even numbers) had an intra-surgery preset marking line. The complications of lacrimal duct mucosa injury, hemorrhage, perforation (false passage), eyelid edema and postoperative hemorrhage were observed and recorded. The data were analyzed by a Chi-square test. \n \n \nResults: \nIn the observation group, the number of preset marking lines could be clearly observed during surgery, and combined with the position of the lacrimal endoscope, could be determined by the anatomical characteristics of the lacrimal passage. One marker line could be observed in the lacrimal canaliculi. The convergence of two marker lines could be observed in the common canaliculus. Two marker lines with an enlarged space could be observed in the lacrimal sac. Two marker lines with mucosal folds could be observed in the nasolacrimal duct. The incidence of lacrimal mucosal injury was 16% (χ2=8.543, P=0.003), hemorrhage incidence was 13% (χ2=8.718, P=0.003) and eyelid edema incidence was 10% (χ2=4.069, P=0.044) in the observation group, which were significantly lower than the incidences in the control group (52%, 52% and 35%, respectively). One case of perforation (false passage) occurred in the control group, which was not statistically significant compared with the observation group (χ2=0.001, P=0.973). There was no statistically significant difference in the incidence of postoperative hemorrhage between the groups (χ2=1.898, P=0.168). Moreover, all patients in the two groups had a small amount of hemorrhage, which did not affect the operation after intraoperative water injection. Patients with a small amount of postoperative hemorrhage stopped bleeding within 2 days. \n \n \nConclusions: \nThe application of preset marking lines for lacrimal endoscopic surgery can better control the endoscopic examination and surgery, and can accurately identify the location site of the surgery, which can reduce the incidence of surgical complications. \n \n \nKey words: \nlacrimal endoscope; lacrimal duct stents; preset marker line; lacrimal duct obstruction","PeriodicalId":10142,"journal":{"name":"Chinese Journal of Optometry & Ophthalmology","volume":"39 1","pages":"64-68"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Optometry & Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-845X.2020.01.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the clinical application value of a preset marking line in lacrimal endoscopic surgery and evaluate its effect on surgical complications. Methods: This was a prospective analysis of clinical data from 60 patients (60 eyes) with lacrimal duct obstruction who had lacrimal endoscopic surgery in Changshu No.2 People's Hospital from June 2015 to December 2018. All patients were divided into two groups, a control group or observation group according to the even or odd numbers assigned to hospital patients. The control group (odd numbers) had no intra-surgery preset marking line. The observation group (even numbers) had an intra-surgery preset marking line. The complications of lacrimal duct mucosa injury, hemorrhage, perforation (false passage), eyelid edema and postoperative hemorrhage were observed and recorded. The data were analyzed by a Chi-square test. Results: In the observation group, the number of preset marking lines could be clearly observed during surgery, and combined with the position of the lacrimal endoscope, could be determined by the anatomical characteristics of the lacrimal passage. One marker line could be observed in the lacrimal canaliculi. The convergence of two marker lines could be observed in the common canaliculus. Two marker lines with an enlarged space could be observed in the lacrimal sac. Two marker lines with mucosal folds could be observed in the nasolacrimal duct. The incidence of lacrimal mucosal injury was 16% (χ2=8.543, P=0.003), hemorrhage incidence was 13% (χ2=8.718, P=0.003) and eyelid edema incidence was 10% (χ2=4.069, P=0.044) in the observation group, which were significantly lower than the incidences in the control group (52%, 52% and 35%, respectively). One case of perforation (false passage) occurred in the control group, which was not statistically significant compared with the observation group (χ2=0.001, P=0.973). There was no statistically significant difference in the incidence of postoperative hemorrhage between the groups (χ2=1.898, P=0.168). Moreover, all patients in the two groups had a small amount of hemorrhage, which did not affect the operation after intraoperative water injection. Patients with a small amount of postoperative hemorrhage stopped bleeding within 2 days. Conclusions: The application of preset marking lines for lacrimal endoscopic surgery can better control the endoscopic examination and surgery, and can accurately identify the location site of the surgery, which can reduce the incidence of surgical complications. Key words: lacrimal endoscope; lacrimal duct stents; preset marker line; lacrimal duct obstruction
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预设标记线在泪道内镜手术中的临床应用价值
目的:探讨预设标记线在泪道内窥镜手术中的临床应用价值,并评价其对手术并发症的影响。方法:前瞻性分析常熟市第二人民医院2015年6月至2018年12月行泪道内窥镜手术的60例(60眼)泪道梗阻患者的临床资料。所有患者按照医院患者编号的奇数或偶数分为对照组和观察组。对照组(奇数)术中无预设标记线。观察组(偶数)术中预设标线。观察并记录泪管黏膜损伤、出血、穿孔(假通道)、眼睑水肿、术后出血等并发症。数据采用卡方检验分析。结果:观察组术中可清晰观察到预设标记线的数量,并结合泪道内窥镜的解剖特点,可确定泪道的位置。泪小管内可见一条标记线。在总小管处可观察到两条标记线的汇合。泪囊内可见两条标记线,空间增大。鼻泪管内可见两条带粘膜褶皱的标记线。观察组患者泪粘膜损伤发生率为16% (χ2=8.543, P=0.003),出血发生率为13% (χ2=8.718, P=0.003),眼睑水肿发生率为10% (χ2=4.069, P=0.044),均显著低于对照组(分别为52%、52%和35%)。对照组出现1例穿孔(假通道),与观察组比较差异无统计学意义(χ2=0.001, P=0.973)。两组术后出血发生率比较,差异无统计学意义(χ2=1.898, P=0.168)。两组患者均有少量出血,术中注水后均不影响手术。术后少量出血患者2天内止血。结论:泪道内窥镜手术应用预设标记线可以更好地控制内镜检查和手术,并能准确识别手术的位置部位,减少手术并发症的发生。关键词:泪道内窥镜;泪管支架;预设标记线;泪道阻塞
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Practice and Effectiveness of COVID-19 RNA Detection in the Prevention and Control of Ophthalmic Hospital Correct Choice of Goggles and Anti-fog Guidance Duringthe Epidemic Period of COVID-19 2019-nCoV and Eye, What We Know and What We Should Do Clinical Application Value of a Preset Marking Line in Lacrimal Endoscopic Surgery Characteristics of Macular Microvascular Changes in Patients with Systemic Lupus Erythematosus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1